sq-11725 has been researched along with Cardiovascular Pregnancy Complications in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoussou, M; Kambiré, Y; Konaté, L; Millogo, GR; Nebié, LV; Niakara, A; Sib, E | 1 |
| Borer, JS; Moses, JW | 1 |
| Fox, RE; Marx, C; Stark, AR | 1 |
1 review(s) available for sq-11725 and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
2 other study(ies) available for sq-11725 and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Right ventricular outflow tract tachycardia worsened during pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide; Hospitalization; Humans; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia, Ventricular | 2015 |
Neonatal effects of maternal nadolol therapy.
Topics: Female; Fetal Distress; Growth Disorders; Humans; Hypertension; Hypoglycemia; Infant, Newborn; Male; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Propanolamines | 1985 |